NCT03399877

Brief Summary

Uroflowmetry(UF) has been the standard first-line diagnostic tool for the evaluation of pediatric voiding dysfunction. But recently, UF combined with pelvic flow electromyography(EMG) is emphasized and recommended to analyze the separate contributions of the detrusor and bladder outlet and sole UF is discouraged except for the follow-up study after abnormal UF/EMG result(Bauer et al., 2015). However, electrode itself can disturb pelvic floor relaxation and there is no evidence about necessity of consecutive UF/EMG test. Therefore, the investigators are going to compare three different methods (Primary-Secondary: UF/EMG-UF/EMG, UF/EMG-sole UF, sole UF-UF/EMG)

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
51

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 4, 2017

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

December 22, 2017

Completed
26 days until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

January 16, 2019

Status Verified

January 1, 2019

Enrollment Period

1.8 years

First QC Date

December 22, 2017

Last Update Submit

January 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • maximum flow rate(Qmax=cc/s)

    The maximum flow rate is the most important uroflowmetry index to diagnose bladder outlet obstruction or bladder contractility.

    One day

Secondary Outcomes (3)

  • Uroflow curve pattern

    One day

  • post void residual

    One day

  • synergy or dyssynergy between the bladder and the pelvic floor.

    One day

Study Arms (3)

Combining electromygraphy with uroflowmetry

ACTIVE COMPARATOR

Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography

Biological: Combining electromyography with uroflowmetry (group A)

Uroflowmetry

ACTIVE COMPARATOR

Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform uroflowmetry solely.

Biological: Uroflowmetry(Group B)

Uroflowmetry-Combining electromygraphy with uroflowmetry

EXPERIMENTAL

Children who assigned Group C firstly perform uroflowmetry solely. and subsequently perform uroflowmetry-electromyography.

Biological: Uroflowmetry-Combining electromyography with uroflowmetry (Group C)

Interventions

Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography again.

Combining electromygraphy with uroflowmetry

Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform sole uroflowmetry.

Uroflowmetry

Children who assigned Group C firstly perform sole uroflowmetry and subsequently perform uroflowmetry-electromyography.

Uroflowmetry-Combining electromygraphy with uroflowmetry

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \) children aged 5 to 11.9 who visit pediatric urology department for enuresis.

You may not qualify if:

  • If children have experience of performing uroflowmetry or uroflowmetry-electromyography.
  • If children do not cooperate on performing the test
  • If enuresis is caused by neurological or anatomical problem.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Urology,

Seoul, 03722, South Korea

RECRUITING

MeSH Terms

Conditions

Enuresis

Condition Hierarchy (Ancestors)

Urination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesBehavioral SymptomsBehaviorElimination DisordersMental Disorders

Central Study Contacts

Yong Seung Lee, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Children who meet the inclusion criteria and no exclusion criteria are assigned to perform one of the three test protocols in order of registration according to a computer gererated randomization list. Children who assigned group A perform uroflowmetry-electromyography for the first and subsequently perform uroflowmetry-electromyography again. Children who assigned Group B perform uroflowmetry-electromyography for the first, and subsequently perform sole uroflowmetry. Children who assigned Group C firstly perform sole uroflowmetry and subsequently perform uroflowmetry-electromyography.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 22, 2017

First Posted

January 17, 2018

Study Start

December 4, 2017

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

January 16, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations